Exact Mass: 470.3118
Exact Mass Matches: 470.3118
Found 500 metabolites which its exact mass value is equals to given mass value 470.3118
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
17,23-Epoxy-29-hydroxy-27-norlanost-8-ene-3,15,24-trione
17,23-Epoxy-29-hydroxy-27-norlanost-8-ene-3,15,24-trione is found in herbs and spices. 17,23-Epoxy-29-hydroxy-27-norlanost-8-ene-3,15,24-trione is from Muscari comosum (tassel hyacinth From Muscari comosum (tassel hyacinth). 17,23-Epoxy-29-hydroxy-27-norlanost-8-ene-3,15,24-trione is found in herbs and spices.
Ceanothine C
Ceanothine C is found in tea. Ceanothine C is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea
(3beta,17alpha,23S)-17,23-Epoxy-3,29-dihydroxy-27-norlanosta-7,9(11)-diene-15,24-dione
(3beta,17alpha,23S)-17,23-Epoxy-3,29-dihydroxy-27-norlanosta-7,9(11)-diene-15,24-dione is found in herbs and spices. (3beta,17alpha,23S)-17,23-Epoxy-3,29-dihydroxy-27-norlanosta-7,9(11)-diene-15,24-dione is a constituent of Muscari comosum (tassel hyacinth) Constituent of Muscari comosum (tassel hyacinth). (3beta,17alpha,23S)-17,23-Epoxy-3,29-dihydroxy-27-norlanosta-7,9(11)-diene-15,24-dione is found in herbs and spices.
19alpha-19-Hydroxy-3,11-dioxo-12-ursen-28-oic acid
19alpha-19-Hydroxy-3,11-dioxo-12-ursen-28-oic acid is found in herbs and spices. 19alpha-19-Hydroxy-3,11-dioxo-12-ursen-28-oic acid is a constituent of Sanguisorba officinalis (burnet bloodwort). Constituent of Sanguisorba officinalis (burnet bloodwort). 19alpha-19-Hydroxy-3,11-dioxo-12-ursen-28-oic acid is found in tea and herbs and spices.
(9E)-10-Nitrooctadec-9-enoylcarnitine
(9E)-10-nitrooctadec-9-enoylcarnitine is an acylcarnitine. More specifically, it is an (9E)-10-nitrooctadec-9-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (9E)-10-nitrooctadec-9-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (9E)-10-nitrooctadec-9-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(9E)-9-Nitrooctadec-9-enoylcarnitine
(9E)-9-nitrooctadec-9-enoylcarnitine is an acylcarnitine. More specifically, it is an (9E)-9-nitrooctadec-9-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (9E)-9-nitrooctadec-9-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (9E)-9-nitrooctadec-9-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
DG(2:0/PGF2alpha/0:0)
DG(2:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/2:0/0:0)
DG(PGF2alpha/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGF2alpha)
DG(2:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/0:0/2:0)
DG(PGF2alpha/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/PGE1/0:0)
DG(2:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGE1/2:0/0:0)
DG(PGE1/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGE1)
DG(2:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGE1/0:0/2:0)
DG(PGE1/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/PGD1/0:0)
DG(2:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGD1/2:0/0:0)
DG(PGD1/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGD1)
DG(2:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGD1/0:0/2:0)
DG(PGD1/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Zhankuic acid B
A steroid acid that is ergosta-8,24(28)-dien-26-oic acid substituted by a hydroxy group at position 3, a methyl group at position 4 and oxo groups at positions 7 and 11 (the 3alpha,4alpha,5alpha stereoisomer). Isolated from Antrodia cinnamomea and Antrodia camphorata, it exhibits cytotoxic, anticholinergic and antiserotonergic activities.
2H-Pyran-2-one,3-[[(1R,4aR,5S,6S,8aR)-6-(acetyloxy)decahydro-5,8a-dimethyl-2-methylene-5-(4-methyl-3-penten-1-yl)-1-naphthalenyl]methyl]-4-hydroxy-5,6-dimethyl-,rel-(-)-
Ulmoidol
Ulmoidol is a natural product found in Ilex kaushue and Eucommia ulmoides with data available.
ent-14-labden-8beta,19-diol 13alpha-O-alpha-L-rhamnopyranoside
2-((2E,6E,10E)-5-acetoxy-12-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinol|2-<(2E,6E,10E)-5-acetoxy-12-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinol
3beta-hydroxy-1,11-dioxo-ergosta-8,24(28)-diene-4alpha-carboxylic acid
Ac-(3beta,5alpha,25R)-3-Hydroxyspirost-9(11)-en-12-one
1-methyl-L-proline (4S)-7t-sec-(or iso)butyl-3t-isopropyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Ceanothin C|ceanothine-C
(5S,10S,13R,17R,20S,21R,22R,23S,24R)-21,23;22,28-diepoxy-21,24-dihydroxystigmasta-8,14-dien-3-one|vernoanthelcin I
(R)-methyl 2-{3-[(E)-3,7-dimethylocta-2,6-dien-1-yl]-2,5-dihydroxyphenyl}-2-[(1S,2S,5S)-2-hydroxy-5-isopropyl-2-methylcyclohex-3-en-1-yl]acetate|melissifoliane A
(E)-methyl 2-{3-[(E)-3,7-dimethylocta-2,6-dien-1-yl]-2,5-dihydroxyphenyl}-4-hydroxy-5,9-dimethyldeca-5,8-dienoate|melissifoliane B
3beta,23-dihydroxy-1-oxo-30-norolean-12,20(29)-dien-28-oic acid|euscaphic acid G
ent-14-labden-8beta-ol 13alpha-O-beta-D-glucopyranoside
24-hydroxy-A(1)-nor-2,20(29)-lupadien-27,28-dioic acid|gouanic acid B
Correllogenin-acetat|Correlogenin-acetat|Correlogenin-acetat; Neobotogenin-acetat|O-Acetyl-neobotogenin
1-methyl-L-proline (4S)-3xi-ethyl-7t-isobutyl-3xi-methyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Ceanothin-D|ceanothine-D
(25S)-18-acetoxy-3-oxocholesta-1,4-dien-26-oic acid
2-((2E,6E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl)-6-methylhydroquinol|2-<(2E,6E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl>-6-methylhydroquinol
8alpha,15,16-trihydroxy-labd-13E-ene-8-O-fucopyranoside
(24R)-27-nor-5alpha-cholestane-3beta,4beta,6alpha,8,14,15alpha,24-heptaol
2,15alpha,22beta-trihydroxy-3-methoxy-24,29-dinor-1,3,5(10)-friedelatriene-21-one
11alpha,12alpha-EPOXY-3beta,23-DIHYDROXY-30-NOROLEAN-20(29)-EN-28,13beta-OLIDE
Siraitic Acid B
BW45NB63RE
11alpha,12alpha-epoxy-3beta,23-dihydroxy-30-nor-olean-20(29)-en-28,13beta-olide is a gamma-lactone. It has a role as a metabolite. 11alpha,12alpha-Epoxy-3beta,23-dihydroxy-30-norolean-20(29)-en-28,13beta-olide is a natural product found in Paeonia lactiflora and Paeonia rockii with data available. See also: Paeonia lactiflora root (part of). A natural product found in Paeonia rockii subspeciesrockii.
3-Hydroxyspirost-9(11)-en-12-one, 3-Ac
Origin: Plant; SubCategory_DNP: The sterols, Cholestanes
Ala Lys Pro Arg
Ala Lys Arg Pro
Ala Pro Lys Arg
Ala Pro Arg Lys
Ala Arg Lys Pro
Ala Arg Pro Lys
Ile Lys Asn Pro
Ile Lys Pro Asn
Ile Asn Lys Pro
Ile Asn Pro Lys
Ile Pro Lys Asn
Ile Pro Asn Lys
Lys Ala Pro Arg
Lys Ala Arg Pro
Lys Ile Asn Pro
Lys Ile Pro Asn
Lys Lys Pro Val
Lys Lys Val Pro
Lys Leu Asn Pro
Lys Leu Pro Asn
Lys Asn Ile Pro
Lys Asn Leu Pro
Lys Asn Pro Ile
Lys Asn Pro Leu
Lys Pro Ala Arg
Lys Pro Ile Asn
Lys Pro Lys Val
Lys Pro Leu Asn
Lys Pro Asn Ile
Lys Pro Asn Leu
Lys Pro Gln Val
Lys Pro Arg Ala
Lys Pro Val Lys
Lys Pro Val Gln
Lys Gln Pro Val
Lys Gln Val Pro
Lys Arg Ala Pro
Lys Arg Pro Ala
Lys Val Lys Pro
Lys Val Pro Lys
Lys Val Pro Gln
Lys Val Gln Pro
Leu Lys Asn Pro
Leu Lys Pro Asn
Leu Asn Lys Pro
Leu Asn Pro Lys
Leu Pro Lys Asn
Leu Pro Asn Lys
Asn Ile Lys Pro
Asn Ile Pro Lys
Asn Lys Ile Pro
Asn Lys Leu Pro
Asn Lys Pro Ile
Asn Lys Pro Leu
Asn Leu Lys Pro
Asn Leu Pro Lys
Asn Pro Ile Lys
Asn Pro Lys Ile
Asn Pro Lys Leu
Asn Pro Leu Lys
Pro Ala Lys Arg
Pro Ala Arg Lys
Pro Ile Lys Asn
Pro Ile Asn Lys
Pro Lys Ala Arg
Pro Lys Ile Asn
Pro Lys Lys Val
Pro Lys Leu Asn
Pro Lys Asn Ile
Pro Lys Asn Leu
Pro Lys Gln Val
Pro Lys Arg Ala
Pro Lys Val Lys
Pro Lys Val Gln
Pro Leu Lys Asn
Pro Leu Asn Lys
Pro Asn Ile Lys
Pro Asn Lys Ile
Pro Asn Lys Leu
Pro Asn Leu Lys
Pro Gln Lys Val
Pro Gln Val Lys
Pro Arg Ala Lys
Pro Arg Lys Ala
Pro Val Lys Lys
Pro Val Lys Gln
Pro Val Gln Lys
Gln Lys Pro Val
Gln Lys Val Pro
Gln Pro Lys Val
Gln Pro Val Lys
Gln Val Lys Pro
Gln Val Pro Lys
Arg Ala Lys Pro
Arg Ala Pro Lys
Arg Lys Ala Pro
Arg Lys Pro Ala
Arg Pro Ala Lys
Arg Pro Lys Ala
Val Lys Lys Pro
Val Lys Pro Lys
Val Lys Pro Gln
Val Lys Gln Pro
Val Pro Lys Lys
Val Pro Lys Gln
Val Pro Gln Lys
Val Gln Lys Pro
Val Gln Pro Lys
(5Z,7E)-(1S,3R,25R)-26,26,26-trifluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R,25S)-26,26,26-trifluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
17,23-Epoxy-29-hydroxy-27-norlanost-8-ene-3,15,24-trione
(3beta,17alpha,23S)-17,23-Epoxy-3,29-dihydroxy-27-norlanosta-7,9(11)-diene-15,24-dione
(25R)-26,26,26-trifluoro-1alpha,25-dihydroxyvitamin D3
(25S)-26,26,26-trifluoro-1alpha,25-dihydroxyvitamin D3
CIS-1,2-DIBORONO-1,2-DIPHENYLETHYLENE, DIPINACOL ESTER
butyl prop-2-enoate,ethenyl acetate,2-ethylhexyl prop-2-enoate,prop-2-enoic acid
2-[3-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1-propenyl]-1-ethyl-3,3-dimethyl-3H-indolium inner salt
Phenol,4,4-[thiobis(methylene)]bis[2,6-bis(1,1-dimethylethyl)-
(4alpha,5alpha,7beta,25S)-7-Hydroxy-4-methyl-3,11-dioxoergosta-8,24(28)-dien-26-oic acid
(25R)-26,26,26-trifluoro-1alpha,25-dihydroxyvitamin D3/(25R)-26,26,26-trifluoro-1alpha,25-dihydroxycholecalciferol
Methymycin(1+)
An organic cation that is the conjugate acid of methymycin, obtained by protonation of the tertiary amino group; major species at pH 7.3.
Neomethymycin(1+)
An organic cation that is the conjugate acid of neomethymycin, obtained by protonation of the tertiary amino group; major species at pH 7.3.
19alpha-19-Hydroxy-3,11-dioxo-12-ursen-28-oic acid
Minabeolide 8
A withanolide that is (22R,25S)-22,26-epoxycholest-4-en-26-one substituted by an oxo group at position 3 and an alpha-acetoxy group at position 11. Isolated from Paraminabea acronocephala, it exhibits anti-inflammatory activity.
4-[4-[[[1-(2-methylpropyl)-3-pyrrolidinyl]methylamino]-oxomethyl]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester
(2R,3S,4S,4aR,5aS,6aR,8R,9S,11S,12aS,13aR,14S,15S,15aS)-9-(hydroxymethyl)-3,4,11,14-tetramethyloctadecahydro-3H-spiro[furan-2,2-pyrano[2,3:6,7]oxepino[2,3:5,6]pyrano[3,2-b]oxocine]-8,15-diol
2,3-Dihydroxypropyl (3-hexadecoxy-2-hydroxypropyl) hydrogen phosphate
[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-hydroxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
n-[3-ethyl-5,8-dihydroxy-3-methyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-methylpyrrolidine-2-carboximidic acid
(1s,3as,3bs,9ar,9bs,11as)-1-hydroxy-1-[(1r)-1-[(1r,2r,4r,6s)-2-methoxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-9-one
n-methyl-5-(n-methylformamido)-3-[(2e,6e,11z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]imidazole-4-carboximidic acid
2-({5-[2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl}oxy)-6-methyloxane-3,4,5-triol
(1s,2r,5r,6s,9r,10r,13r,14r,15r,18s)-6-(hydroxymethyl)-2,6,9-trimethyl-15-(prop-1-en-2-yl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icos-7-ene-1,18-dicarboxylic acid
3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-4-one
6-(hydroxymethyl)-2,6,9-trimethyl-15-(prop-1-en-2-yl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icos-7-ene-1,18-dicarboxylic acid
(1s,2s,4ar,5r,8ar)-5-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-yl acetate
(2s,3r,4s,5s,6r)-2-{[(3s)-5-[(1s,2r,4ar,8ar)-2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-[(1s,4ar,5s,6r,8ar)-5-{[5-(acetyloxy)-2-hydroxy-3-methylphenyl]methyl}-5,6,8a-trimethyl-2-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]propanoic acid
(2r,6r)-6-[(1r,3ar,4r,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,3h,3ah,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid
2-{[4-(5-hydroxy-3-methylpent-3-en-1-yl)-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol
n-methyl-5-(n-methylformamido)-3-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)imidazole-4-carboximidic acid
(2s,6r)-6-[(1s,3ar,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,3h,3ah,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid
3-[(1s,4ar,5s,6s,8ar)-5-{[5-(acetyloxy)-2-hydroxy-3-methylphenyl]methyl}-5,6,8a-trimethyl-2-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]propanoic acid
11α,12α-epoxy-3β,23-dihydroxy-30-norolean-20-en-28,13β-olide
{"Ingredient_id": "HBIN000338","Ingredient_name": "11\u03b1,12\u03b1-epoxy-3\u03b2,23-dihydroxy-30-norolean-20-en-28,13\u03b2-olide","Alias": "NA","Ingredient_formula": "C29H42O5","Ingredient_Smile": "CC12CCC(C(C1CCC3(C2C4C(O4)C56C3(CCC7(C5CC(=C)CC7)C(=O)O6)C)C)(C)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41440","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11α, 12α-epoxy--3β, 23dihy-droxyolean-28, 13β-olide
{"Ingredient_id": "HBIN000339","Ingredient_name": "11\u03b1, 12\u03b1-epoxy--3\u03b2, 23dihy-droxyolean-28, 13\u03b2-olide","Alias": "11\u03b1,12\u03b1-epoxy-3\u03b2,23-dihydroxyolean-28,13\u03b2-olide","Ingredient_formula": "C29H42O5","Ingredient_Smile": "CC12CCC(C(C1CCC3(C2C4C(O4)C56C3(CCC7(C5CC(=C)CC7)C(=O)O6)C)C)(C)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41465;41441","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}